Results 91 to 100 of about 1,043 (146)

CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial. [PDF]

Front Immunol
Tang J, Wen Y, Yang T, Liu Q, Li F, Wang L, Gu Z, Wu Y, Luan S, Ma C, Wei Y, Qian K, Dou L, Liu D.   +13 more
europepmc   +1 more source

Probable reactivation from latency of multidrug-resistant cytomegalovirus in a lung transplant recipient: A case report. [PDF]

Am J Transplant
Wagner JA, Yakubu R, Whelan AM, Hays SR, Karita HCS, Schwartz BS, Limaye AP.   +6 more
europepmc   +1 more source

How Should Cytomegalovirus Infection Be Managed in Allogeneic Hematopoietic Stem Cell Transplant Recipients? A Clinical Grand Round. [PDF]

Infect Chemother
Nho D, Lee R, Cho SY, Lee DG.
europepmc   +1 more source

Managing Cytomegalovirus Infection in Lung Transplant Recipients in Real Life: Results of a French Multicenter Survey. [PDF]

Transpl Int
Goletto T, El Husseini K, Roux A, Briard M, Dauriat G, Renaud-Picard B, Merveilleux du Vignaux C, Falque L, Coiffard B, Villeneuve T, Demant X, Tissot A, Mouren D, Carlier FM, Alain S, Messika J, Bunel V.   +16 more
europepmc   +1 more source

CMV Viremia and Colitis in Simultaneous Pancreas-Kidney Transplantation. [PDF]

Am J Case Rep
Singh S, Rajani AJ, Karatela S, Patel M, Amin JV, Gandhi D, Oring J.   +6 more
europepmc   +1 more source

Cytomegalovirus infections in thoracic organ transplant recipients: Updates on prevention, treatment, and immune monitoring. [PDF]

JHLT Open
Collis BJ, Heldman MR, Wolfe CR.
europepmc   +1 more source